Patent · US Active

Anti-VEGF antibodies

US7910098B2 · kind B2 · utility

20Cited by
23References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 1, 2008
Grant dateMar 22, 2011
Priority date—
Expiry dateJan 2, 2029

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/475
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention herein provides isolated antibodies that bind to VEGF. The invention further provides methods of making anti-VEGF antibodies, and polynucleotides encoding anti-VEGF antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.